Amlapitta is one of the most common gastrointestinal disorders described in Ayurveda, characterized by symptoms such as Tikta–Amlodgara (sour and bitter belching), Hrita–Kantha Daha (burning sensation in chest and throat), Aruchi (loss of appetite), and Utklesha (nausea). It mainly results from impaired Agni and aggravation of Pitta Dosha due to improper dietary habits, stress, and irregular lifestyle. In contemporary medicine, Amlapitta can be correlated with acid peptic disorders such as gastritis and hyperacidity. The present clinical study was conducted to evaluate the efficacy of Hingvadi Yoga in the management of Amlapitta and to compare its therapeutic effect with Avipattikara Churna, a well-known classical formulation used for Pittaja disorders. A randomized controlled clinical study was carried out on 40 patients clinically diagnosed with Amlapitta, selected from the OPD and IPD of the Department of Kayachikitsa at Dhanvantari Ayurvedic Medical College and Hospital, Karnataka. The patients were randomly divided into two groups consisting of 20 patients each. Group A received Hingvadi Yoga (5 g twice daily after meals with lukewarm water), while Group B received Avipattikara Churna (5 g twice daily after meals with lukewarm water) for a duration of 30 days. Assessment of therapeutic response was done based on subjective parameters including Tikta–Amlodgara, Hrita–Kantha Daha, Aruchi, and Utklesha using a graded scoring pattern. Follow-up observations were recorded on the 0th, 10th, 20th, and 30th day of treatment. The ingredients of Hingvadi Yoga such as Hingu, Katakaphala, Chincha, and Ghrita possess Deepana, Pachana, Vata-Kapha Shamana, and Agni-stimulating properties which help in correcting digestive disturbances and reducing the pathological manifestation of Amlapitta. The study aims to highlight the clinical effectiveness of this formulation in comparison with Avipattikara Churna. The findings of the study may provide supportive evidence for the use of classical Ayurvedic formulations in the management of Amlapitta and contribute to the integration of traditional therapeutic approaches in gastrointestinal disorders.
Dr. Onkar Kande* (Mon,) studied this question.